Autolus Therapeutics AUTL 深 沪
等待开盘 05-14 09:30:00 美东时间
1.71
+0.110
+6.88%
华盛通- 最 高1.7499
- 今 开1.59
- 成交量 199.60万股
- 最 低 1.57
- 昨 收 1.60
- 总市值 4.55亿
- 52周最高 2.70
- 市盈率 静 --
- 换手率 0.75%
- 52周最低 1.175
- 委 比 68.14%
- 总股本 2.66亿
- 历史最高 53.24
- 量 比 1.42
- 振 幅 11.24%
- 历史最低 1.105
- 每 手 1
- 风险率 0.36%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Autolus Therapeutics Plans To Cut Workforce By ~13% As Part Of Initiative To Enhance Operational Efficiency, Lower Operating Expenses
Autolus Therapeutics plc (Nasdaq: AUTL), a commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies and candidates, today announced a strategic
04-30 04:24
Autolus Highlights ALL Opportunity and AUCATZYL CAR-T Platform
Autolus Therapeutics ( ($AUTL) ) just unveiled an update. On April 8, 2026, Aut...
04-09 05:13
Service Properties Trust, ConocoPhillips And Other Big Stocks Moving Lower In Monday's Pre-Market Session
US stock futures up, Nasdaq 100 gains 100 pts. Service Properties Trust (SVC) drops 4% in pre-market trading. Other decliners: MGRT, UP, CDZI, LCTX, KEP, AUTL, EOG, ANGX, COP.
04-06 20:03
美股大行评级 | 存储分歧大！花旗大砍17%将美光目标价从510降至425美元；Bernstein上调希捷科技目标价从500升至620美元
今日重点评级关注：Maxim Group：上调Theriva Biologics评级至"买入"，目标价1美元；HC Wainwright & Co.：维持Bicara Therapeutics"买入"评级，目标价从40美元升至42美元
04-01 16:34
美股大行评级 | 能源股再或大行青睐！康菲石油、雪铁龙、埃克森美孚、响尾蛇能源等获上调目标价；Unity评级分歧大，大摩、美银上调，富国银行下调
今日重点评级关注：花旗：维持Biomea Fusion"买入"评级，目标价从6美元升至7美元；Chardan Capital：维持Hyperion DeFi"买入"评级，目标价从7.75美元升至8.25美元
03-30 11:49
Needham Reiterates Buy on Autolus Therapeutics, Maintains $10 Price Target
Needham analyst Gil Blum reiterates Autolus Therapeutics (NASDAQ:AUTL) with a Buy and maintains $10 price target.
03-28 00:21
Autolus Highlights AUCATZYL Launch and Pipeline Advancements
Autolus Therapeutics ( ($AUTL) ) has provided an update. Autolus Therapeutics r...
03-27 21:11
Earnings Scheduled For March 27, 2026
Companies Reporting Before The Bell • Instil Bio (NASDAQ:TIL) is expected to re...
03-27 19:11
Autolus Therapeutics Q4 EPS $(0.34) Misses $(0.24) Estimate, Sales $24.289M Miss $24.481M Estimate
Autolus Therapeutics (NASDAQ:AUTL) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.24) by 41.08 percent. This is a 277.78 percent decrease over losses of $(0.09) per
03-27 19:01
